The rare monogenic arrhythmogenic disorder catecholaminergic polymorphic ventricular tachycardia (CPVT) is characterised by episodic ventricular dysrhythmia triggered by exercise or emotion in individuals without structural cardiac defects. Next generation sequencing has now become more widely accessible and RYR2 in its entirety can be screened relatively easily. This has led to an increase in the number of RYR2 variants being reported in individuals with cardiac dysrhythmia. The majority of RYR2 variants are missense changes that lead to increased channel activity and the rarity of these variants makes it difficult to determine their pathogenicity, thus the majority are classified as being of unknown significance (VUS). We collated RYR2 variants reported in individuals with or suspected of having CPVT and classified them using a statistical method and the ACMG guidelines. Where possible the phenotype associated with each variant was recorded to determine any genotype-phenotype correlations. Recently RYR2 variants have also been shown to cause ventricular arrhythmias by a loss of function mechanism. We used five computational splice prediction tools and an ex vivo splicing assay to investigate whether 329 rare variants in RYR2 from a cohort of individuals undergoing genetic testing for a ventricular arrhythmia alter splicing. Ten RYR2 variants were predicted to disrupt splicing by multiple computational tools. Of these, none altered splicing in an ex vivo splicing assay.
Share this Article
Related Content In Arrhythmia
Update on Etripamil Nasal Spray for the At-home Treatment of Acute Paroxysmal Supraventricular Tachycardia
Heart International. 2021;15(1):Online ahead of journal publication
Paroxysmal supraventricular tachycardia (PSVT) defines a group of cardiac arrhythmias where the underlying mechanism is dependent upon structures at or above the level of the atrioventricular node. The recent PRE-EMPT study retrospectively evaluated health records of over 4.2 million people in the USA, estimating PSVT incidence at 73/100,000, and national prevalence at 168/100,000 (translating into […]
Rhythm Disorders in Endocrinology
European Journal of Arrhythmia & Electrophysiology. 2021;7(1):Online ahead of journal publication
Several closely regulated ion channels are involved in the various phases of the myocardial action potential (phases 0–4) (Figure 1).1 In the absence of neuroendocrine and other regulatory signals, the pacing rate of the sinoatrial node is 100 beats per minute (bpm). However, heart rate is not fixed, and varies along with cardiac output in order […]
Supraventricular Tachycardia: Electrocardiogram Diagnosis and Clinical Management for the Non-electrophysiologist
European Journal of Arrhythmia & Electrophysiology. 2021;7(1):Online ahead of journal publication.
Supraventricular tachycardia (SVT) occurs with a prevalence of 2–3/1,000 in the general population and is characterised by atrial rates >100 beats per minute (bpm) at rest. Per definition, SVT originates in the atria or atrioventricular (AV) node tissue above the His bundle.1,2 Diagnosis and clinical management of SVT have been the focus of recent European Society […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!